161 related articles for article (PubMed ID: 30581552)
1. Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer.
Vargas-Ortega G; Balcázar-Hernández L; González-Virla B; Ramírez-Rentería C; Nieto-Guzmán O; Garrido-Mendoza AP; Flores-Maya MA; Mercado M; Victoria MZ
J Thyroid Res; 2018; 2018():9461079. PubMed ID: 30581552
[TBL] [Abstract][Full Text] [Related]
2. Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.
Preda C; Branisteanu D; Armasu I; Danila R; Velicescu C; Ciobanu D; Covic A; Grigorovici A
BMC Surg; 2019 Jul; 19(1):94. PubMed ID: 31311533
[TBL] [Abstract][Full Text] [Related]
3. Differences in Clinicopathological Characteristics of Papillary Thyroid Carcinoma between Symptomatic and Asymptomatic Patients with Primary Hyperparathyroidism.
Liu Y; Guo S; Sang S; Liu J; Qi L; Lv B; Zhang X
Int J Endocrinol; 2021; 2021():9917694. PubMed ID: 34158812
[TBL] [Abstract][Full Text] [Related]
4. Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study.
Jeong C; Kwon HI; Baek H; Kim HS; Lim DJ; Baek KH; Ha J; Kang MI
Endocrinol Metab (Seoul); 2020 Dec; 35(4):925-932. PubMed ID: 33297604
[TBL] [Abstract][Full Text] [Related]
5. Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review.
Cinamon U; Levy D; Marom T
Int Arch Otorhinolaryngol; 2015 Jan; 19(1):42-5. PubMed ID: 25992150
[TBL] [Abstract][Full Text] [Related]
6. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
7. Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism.
Heizmann O; Viehl CT; Schmid R; Müller-Brand J; Müller B; Oertli D
Eur J Med Res; 2009 Jan; 14(1):37-41. PubMed ID: 19258209
[TBL] [Abstract][Full Text] [Related]
8. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
[TBL] [Abstract][Full Text] [Related]
9. Increased thyroid malignancy in patients with primary hyperparathyroidism.
Li L; Li B; Lv B; Liang W; Zhang B; Zeng Q; Turner AG; Sheng L
Endocr Connect; 2021 Aug; 10(8):885-893. PubMed ID: 34261038
[TBL] [Abstract][Full Text] [Related]
10. Accessing the influence of
Hargitai L; Schefner M; Traub-Weidinger T; Haug A; Arikan M; Scheuba C; Riss P
Langenbecks Arch Surg; 2022 May; 407(3):1183-1191. PubMed ID: 35061094
[TBL] [Abstract][Full Text] [Related]
11. Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism.
Carsote M; Nistor C
Diagnostics (Basel); 2023 Jun; 13(11):. PubMed ID: 37296804
[TBL] [Abstract][Full Text] [Related]
12. Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol.
Rubello D; Fig LM; Casara D; Piotto A; Boni G; Pelizzo MR; Shapiro B; Sandrucci S; Gross MD; Mariani G;
Cancer Biother Radiopharm; 2006 Jun; 21(3):194-205. PubMed ID: 16918295
[TBL] [Abstract][Full Text] [Related]
13. Positive
Dugonjić S; Šišić M; Radulović M; Ajdinović B
Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
[TBL] [Abstract][Full Text] [Related]
14. Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease.
Zheng YX; Xu SM; Wang P; Chen L
J Zhejiang Univ Sci B; 2007 Sep; 8(9):626-31. PubMed ID: 17726743
[TBL] [Abstract][Full Text] [Related]
15. Incidental Finding of Papillary Thyroid Carcinoma in the Patients with Primary Hyperparathyroidism.
Yazici P; Mihmanli M; Bozdag E; Aygun N; Uludag M
Eurasian J Med; 2015 Oct; 47(3):194-8. PubMed ID: 26644769
[TBL] [Abstract][Full Text] [Related]
16. The Nexus of Hyperparathyroidism and Thyroid Carcinoma: Insights into Pathogenesis and Diagnostic Challenges-A Narrative Review.
Scerrino G; Paladino NC; Orlando G; Salamone G; Richiusa P; Radellini S; Melfa G; Graceffa G
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202152
[TBL] [Abstract][Full Text] [Related]
17. Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary Hyperparathyroidism.
Xue Y; Ye ZQ; Zhou HW; Shi BM; Yi XH; Zhang KQ
Med Sci Monit; 2016 Nov; 22():4482-4489. PubMed ID: 27867183
[TBL] [Abstract][Full Text] [Related]
18. [Intraoperative monitoring of intact parathyroid hormone (iPTH) in surgery of primary hyperparathyroidism with a new rapid test].
Trupka A; Hallfeldt K; Horn K; Gärtner R; Landgraf R
Chirurg; 2001 May; 72(5):578-83. PubMed ID: 11383071
[TBL] [Abstract][Full Text] [Related]
19. Primary Hyperparathyroidism with Thyroid Cancer: Clinicopathologic Features.
Haciyanli SG; Karaisli S; Suataman B; Karahan F; Haciyanli M
Sisli Etfal Hastan Tip Bul; 2022; 56(2):250-255. PubMed ID: 35990290
[TBL] [Abstract][Full Text] [Related]
20. Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study.
Çetin K; Sıkar HE; Temizkan Ş; Ofluoğlu CB; Özderya A; Aydın K; Gül AE; Küçük HF
World J Surg; 2019 May; 43(5):1243-1248. PubMed ID: 30680499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
